Clinical Trial: Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123363) titled 'Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline' on Aug. 07.

Brief Summary: The primary goal of this study is to assess safety and tolerability of bitopertin in subjects with Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP) and evidence of compensated liver disease.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Protoporphyria

Intervention: DRUG: bitopertin

bitopertin 60 mg will be taken once daily by...